Tygacil - Broad-Spectrum Antibiotic for Empiric Treatment of Serious Infections
Key Data:
Drug (Brand / Generic)
Tygacil (tigecycline)
Company / Licensee
Wyeth Pharmaceuticals
Therapy Class
Glycylcycline
Product Description
Antibiotic
Current Indication
Treatment of complicated intra-abdominal infections and skin and soft tissue infections
Market Sector
Anti-infective
Development Status
Approved US and EU
